Here are relevant reports on : music-therapy-market
-
Veterinary Medical Devices and Supplies Market by Product (Anesthesia, Patient Monitoring, Infusion Pumps, Consumables), Application (Diagnosis, Monitoring, Therapy, Surgical), Animal Type (Companion Animals, Large Animals) - Global Forecast to 2030
The global veterinary medical devices and supplies market, valued at US$2.50 billion in 2024, stood at US$2.66 billion in 2025 and is projected to advance at a resilient CAGR of 6.3% from 2024 to 2030, culminating in a forecasted valuation of US$3.60 billion by the end of the period. The market growth is driven by the rising pet ownership and increasing expenditure on animal healthcare, coupled with the growing prevalence of chronic and infectious diseases in companion and livestock animals.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
Hyperbaric Oxygen Therapy Equipment Market by Product (Hyperbaric Oxygen Chambers, Chamber Accessories, Consumables), Application (Injuries, Infections, Insufficiencies), End User - Global Forecast to 2022
The global hyperbaric oxygen therapy equipment market is expected to reach $3.21 Billion by 2022 from $2.26 Billion in 2017, growing at a CAGR of 7.1% from 2017 to 2022. Rising incidence and prevalence of acute and chronic wounds, ready availability of hyperbaric oxygen therapy systems, and growing popularity of leisure and adventure activities are some of the major driving factors driving the growth of the global hyperbaric oxygen therapy equipment market. However, the high cost of treatment and challenges in reimbursement are hindering the growth of this market to a certain extent.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Europe Patient Engagement Solutions Market by Therapy (Chronic [CVD, Obesity], Women's Health), Functionality (Telehealth, E-Prescribing, Scheduling, Billing, Education), End User (Hospitals, ASCs, Payers, Patients) - Forecast to 2030
The Europe Patient Engagement Solutions market, valued at USD 6.42 billion in 2024, stood at USD 7.35 billion in 2025 and is projected to advance at a resilient CAGR of 12.7% from 2025 to 2030, culminating in a forecasted valuation of USD 13.37 billion by the end of the period. This development is fueled by the changing trend toward value-based and outcome-oriented care, escalating the need to provide continuous interaction with patients outside of clinical care, and an increasing use of digital front-door solutions (patient portals and virtual assistants).
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
CAR T-Cell Therapy Market by Product (Abecma, Breyanzi, Carvykti, Yescarta, Tecartus, Kymriah), Target (CD19, BCMA), Indication (Multiple Myeloma, Leukemia, Lymphoma), Demographic (Adult, Pediatric), Region, Competitive Landscape - Global Forecast to 2031
The global CAR T-cell therapy market, valued at USD 5.98 billion in 2025, stood at USD 6.78 billion in 2026 and is projected to advance at a resilient CAGR of 14.9% from 2026 to 2031, culminating in a forecasted valuation of USD 13.56 billion by the end of the period. The global CAR T-cell therapy market is growing due to rapid technological advances alongside rising investments from large pharma and well-funded biotech's.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Europe Radiation Detection, Monitoring, and Safety Market By Product (Personal & Area Dosimeters, Material & Full-body Monitors), Component (Gas-filled and Solid-state Detectors), Application (Safety & Security, Diagnostics & Therapy) - Forecast to 2031
The Europe Radiation Detection, Monitoring, and Safety market, valued at USD 0.75 billion in 2025, stood at USD 0.83 billion in 2026 and is projected to advance at a resilient CAGR of 9.0% from 2026 to 2031, culminating in a forecasted valuation of USD 1.37 billion by the end of the period. The growth can be attributed to the implementation of strict regulatory mandates, an efficient and well-developed healthcare system, and rising public awareness of occupational and environmental safety in the region.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Hemophilia Treatment Market by Indication (Type A, Type B), Therapy (Replacement (Recombinant, Plasma Derived), Route of Administration, End User - Global Forecast to 2027
The global hemophilia treatment market is projected to reach USD ~15 billion by 2027 from USD 12 Billion in 2022, at a CAGR of 5% during the forecast period. The major players in the global hemophilia market are Bayer Healthcare (Germany), Octapharma AG (Switzerland), Novo Nordisk (Denmark), Kedrion (Italy), Pfizer Inc. (US), Biogen (US) among others.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Leukapheresis Market by Type (Filter, Membrane Separator, Centrifugal Device), Leukopak (Mobilized, Isolated PBMC), Application (Research [Cell & Gene Therapy, Transplantation], Therapeutic), Indication, End User, Region - Global Forecast to 2031
The global Leukapheresis market, valued at USD 83.3 billion in 2025, stood at USD 90.6 billion in 2026 and is projected to advance at a resilient CAGR of 8.9% from 2026 to 2031, culminating in a forecasted valuation of USD 138.7 billion by the end of the period. This growth is driven by the increasing number of therapeutic and manufacturing applications for leukapheresis in hematologic disorders, as well as the rising demand for high-quality starting materials used in cell and gene therapy, including CAR-T, TCR, and NK-cell programs.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Cardiac Rhythm Management Market by Product (Implantable, External Pacemakers, Defibrillators, Cardiac resynchronization therapy (CRT) devices), by End-Users (Hospitals, Home, Ambulatory) Forecasts To 2020
The incidence of cardiovascular diseases (CVD) is increasing with the aging population, changing lifestyle, and increasing stress. It is estimated that 17 million people die of CVD every year. Sudden cardiac arrest (SCA) is the leading cause of death among U.S. adults aged 40 years and above. According to Centre for Disease Control and Prevention (CDC), approximately 250,000 people die every year in the U.S. from SCA.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
U.S. Insomnia Market by Non-Pharmacological Therapy (CBTI, Hypnotherapy), Prescription Sleep Aids (Benzodiazepines, Non-Benzodiazepines (Zaleplon), Orexin Antagonist) & OTC Treatment (Antihistamine, Melatonin, Valerian Root)) - - Global Forecast to 2021
The U.S. insomnia market is categorised into pharmacological treatments and non-pharmacological treatments. The U.S. insomnia pharmacological treatment market is projected to reach USD 4.24 Billion by 2021 from USD 3.38 Billion in 2016, growing at a CAGR of 4.6% from 2016 to 2021. The duration of insomnia can be from a day to years. Based on duration, insomnia is divided into three major categories, namely, transient insomnia (less than a month), short term insomnia (between 1 month and 6 months), and chronic insomnia (more than 6 months).
- Published: January 2017
- Price: $ 4950
- TOC Available:
-
Regenerative Medicine Market by Product (Stem Cell [Autologous, Allogenic], Immunotherapy, Gene Therapy, Tissue Engineering), Application (Musculoskeletal, Cancer, Dermatology, Wound care, Cardiovascular Diseases, Eye Disorders) & Region - Global Forecast to 2028
The global regenerative medicine market, valued at US$13.5 billion in 2022, stood at US$16.0 billion in 2023 and is projected to advance at a resilient CAGR of 25.1% from 2023 to 2028, culminating in a forecasted valuation of US$49.0 billion by the end of the period. The growth of this market is characterized by the increasing collaborations and partnerships by major market players, and the emerging applications in new therapeutic areas. Rising focus on personalized medicine and increasing regulatory approvals in regenerative medicine are also predicted to drive the market.
- Published: January 2024
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
